Clinical and Translational Discovery (Dec 2022)

Targeting CDK12 is a novel therapeutic strategy through disrupting oncogene associated super‐enhancers in metastatic colorectal cancer

Zhijian Kuang,
Chun‐Ming Wong

Affiliations

Zhijian Kuang: State Key Laboratory of Liver Research Department of Pathology Li Ka Shing Faculty of Medicine the University of Hong Kong Hong Kong SAR China
Chun‐Ming Wong: State Key Laboratory of Liver Research Department of Pathology Li Ka Shing Faculty of Medicine the University of Hong Kong Hong Kong SAR China

DOI: https://doi.org/10.1002/ctd2.152
Journal volume & issue: Vol. 2, no. 4
pp. n/a – n/a

Abstract

No abstracts available.

Published in Clinical and Translational Discovery

ISSN: 2768-0622 (Online)
Publisher: Wiley
Country of publisher: Australia
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: https://onlinelibrary.wiley.com/journal/27680622

About the journal